Braidwell »

Oculis Holding shares owned by Braidwell

Quarter-by-quarter ownership of Oculis Holding (OCS) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Oculis Holding

Tip: Access up to 7 years of quarterly data

All positions including Oculis Holding held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oculis Holding by Braidwell

Quarter filed Position value Share count Share price at filing
2026-06-30 $12M 834k 13.87

More positions owned by Braidwell

Caris Life Sciences (CAI)
Hinge Health Cl A (HNGE)
Glaukos (GKOS)
Edgewise Therapeutics (EWTX)
Spyre Therapeutics Com New (SYRE)
Irhythm Technologies (IRTC)
Neogenomics Com New (NEO)
Kodiak Sciences (KOD)
Xenon Pharmaceuticals (XENE)
Alphatec Hldgs Note 0.750% 3/1 (Principal)
Monte Rosa Therapeutics (GLUE)
Dianthus Therapeutics (DNTH)
Neurocrine Biosciences (NBIX)
Alphatec Hldgs Com New (ATEC)
Generate Biomedicines Com Shs (GENB)

View all positions for Braidwell

Top funds holding Oculis Holding

EQT Fund Management S.a r.l.
Gildi - lifeyrissjodur
Standard Life Aberdeen
Millennium Management
Pivotal bioVenture Partners Investment Advisor
Citadel Advisors
Braidwell
Perceptive Advisors
Saturn V Capital Management
Sr One Capital Management
Siren
Ameriprise Financial
Wellington Management Company
Partner Fund Management
Franklin Resources

View all funds holding Oculis Holding